Skip to main content
. 2020 Jul 25;12(8):2055. doi: 10.3390/cancers12082055

Table 1.

Demographic characteristics of statin users and statin non-users among gastric cancer patients after surgery and adjuvant chemotherapy in Taiwan during 1999–2008 in the matched cohort.

Variables Statin Users
(N = 367)
Statin Non-Users
(N = 1468)
p-Value *
No. % No. %
Gender 0.5543
Female 159 43.3 611 41.6
Male 208 56.7 857 58.4
Age at Surgery 0.4388
18–64 172 46.9 655 44.6
≥65 195 53.1 813 55.4
Mean (SD) 64.3 (10.5) 64.1 (12.6) 0.758
Insured Salaries (NTD$/month) a
0+ 70 19.1 277 18.9
1–15,840 38 10.4 154 10.5
15,841–25,000 185 50.4 733 49.9
>25,000 74 20.2 304 20.7
Urbanization Level 0.5232
Very High 106 28.9 395 26.9
High 170 46.3 737 50.2
Moderate 62 16.9 241 16.4
Low 29 7.9 95 6.5
Comorbidities
Hypertension 214 58.3 878 59.8 0.6009
Diabetes Mellitus 122 33.2 467 31.8 0.5996
Alcoholism 8 2.2 23 1.6 0.4150
Smoking-related disorder 40 10.9 166 11.3 0.8244
Chronic kidney disease 13 3.5 64 4.4 0.4848
Liver cirrhosis 14 3.8 61 4.2 0.7682
Chemotherapy Regimen 0.9425
Group 1 (epirubicin-based) 29 7.9 105 7.2
Group 2 (mitomycin-based) 49 13.4 205 14.0
Group 3 (taxanes) 2 0.5 10 0.7
Group 4 (others) b 287 78.2 1148 78.2
Medication
Triglyceride-Lowering Drugs 0.0046
User 19 5.2 35 2.4
Non-user 348 94.8 1433 97.6
Non-Statin Lipid-Lowering Drugs 0.4756
User 8 2.2 24 1.6
Non-user 359 97.8 1444 98.4
ACE Inhibitors 0.9579
User 98 26.7 390 26.6
Non-user 269 73.3 1078 73.4
Aspirin 0.3669
User 123 33.5 529 36.0
Non-user 244 66.5 939 64.0
NSAID 0.7487
User 291 79.3 1175 80.0
Non-user 76 20.7 293 20.0
Death 138 37.6 895 61.0

* Pearson’s chi-square test for categorical variables and t-test for continuous variables. a 1 USD = 32.3 New Taiwan Dollars (NTD) in the year 2008. b Others: cisplatin, carboplatin, oxaliplatin, 5-FU (fluorouracil), capecitabine, TS-1 (tegafur/gimeracil/oteracil), and tegafur.